We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Analytical Cannabis Logo
Home > Resources > Podcasts > Content Piece

Opinionated Science: Psychedelics: A Trip Through Psilocybin and MDMA Research

By Ruairi J Mackenzie

Published: Aug 17, 2021   

On this week’s Opinionated Science, the team take a look at the growing potential of psychedelic medicine.

Hundreds of new clinical trials, exciting new synthetic psychedelics and a universal acceptance that current mental health treatments are not meeting patients’ needs have pushed the mind-altering potential of psychedelics into the medical mainstream.

In this episode, Technology Networks Senior Science Writer Ruairi J Mackenzie takes a deep dive into four leading psychedelic compounds: psilocybin, MDMA, ketamine and DMT.

Read more from this podcast:

Why Does Ketamine Fight Depression? Finding Answers at BNA 2019

Mirror’s Image: Could a Simple Flip Produce a More Effective Ketamine-Based Antidepressant?

The Neuroscience of Psychedelic Drugs: Your Brain on Psilocybin With Frederick Streeter Barrett

Subscribe to Opinionated Science at your favorite podcast platform:

Listen here on Spotify.

Listen here on Apple Podcasts.

Listen here  on Podbean.

Ruairi J Mackenzie

Senior Science Writer

Ruairi started with Technology Networks in January 2018 after completing an undergraduate degree in Neuroscience at the University of Edinburgh and a Master’s in Clinical Neuroscience from the University of Cambridge. As a senior science writer, Ruairi covers a range of scientific news and articles, with a focus on the complexities and curiosities of the brain. Ruairi also looks after search engine optimization efforts on Technology Networks and created the site’s podcast, Opinionated Science, in 2020.


Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter